Protease inhibitors have been isolated from many variable sources; however, the need to identify and characterize new molecules has increased with the discovery of new therapeutic targets and the lack of specificity of already identified compounds with inhibitory activity. The goal of this work was to search for inhibitory activity against four proteolytic enzymes already recognized as therapeutic targets: human neutrophil elastase, dipeptidyl peptidase IV, subtilisin from Bacillus licheniformis and cathepsin K in selected marine invertebrates from the Caribbean Sea. A systematic screening was carried out with selected aqueous extracts belonging to 20 species from seven different phyla: Annelida, Bryozoa, Chordata, Cnidaria, Equinodermata, Mollusca and Porifera, all collected at the coast of Havana (Cuba). All extracts showing initial inhibitory activity were characterized in terms of IC 50 values and specific inhibitory activity (SIA). Model enzymes were used in the case of human neutrophil elastase (porcine pancreatic elastase) and cathepsin K (papain) for the screening and all positive results were confirmed by testing toward the therapeutic targets. Ten extracts were identified showing inhibitory activity against human neutrophil elastase, for which the most promising values were obtained for Nerita peloronta . Only one extract, Bunodosoma granulifera , showed inhibitory activity against dipeptidyl peptidase IV with rather poor values of IC 50 and SIA. Seven extracts showed inhibitory activity against B. licheniformis subtilisin with very good IC 50 and SIA values for Lissodendorix isodyctialis , Cenchritis muricatus , and N. peloronta . Finally, eight extracts were positive for cathepsin K with almost similar parameters values among them. All these results confirmed the richness and potential of the marine invertebrate’s fauna and indicated new promising sources for the identification of natural compounds with potential application in therapeutics.
Rawlings, N.D., Tolle, D.P. and Barrett, A.J. (2004) Evolutionary Families of Peptidase Inhibitors. Biochemical Journal, 378, 705-716. http://dx.doi.org/10.1042/bj20031825
Turk, B. (2006) Targeting Proteases: Successes, Failures and Future Prospects. Nature Reviews Drug Discovery, 5, 785-799. http://dx.doi.org/10.1038/nrd2092
Abbenante, G. and Fairlie, D.P. (2005) Protease Inhibitors in the Clinic. Medicinal Chemistry, 1, 71-104. http://dx.doi.org/10.2174/1573406053402569
Scott, C.J. and Taggart, C.C. (2010) Biologic Protease Inhibitors as Novel Therapeutic Agents. Biochimie, 92, 1681-1688. http://dx.doi.org/10.1016/j.biochi.2010.03.010
Korkmaz, B., Horwitz, M.S., Jenne, D.E. and Gauthier, F. (2010) Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases. Pharmacological Reviews, 62, 726-759. http://dx.doi.org/10.1124/pr.110.002733
Kawabata, K., Hagio, T. and Matsuoka, S. (2002) The Role of Neutrophil Elastase in Acute Lung Injury. European Journal of Pharmacology, 451, 1-10. http://dx.doi.org/10.1016/S0014-2999(02)02182-9
Windhorst, S., Frank, E., Georgieva, D.N., Genov, N., Buck, F., et al. (2002) The Major Extracellular Protease of the Nosocomial Pathogen Stenotrophomonas maltophilia: Characterization of the Protein and Molecular Cloning of the Gene. Journal of Biological Chemistry, 277, 11042-11049. http://dx.doi.org/10.1074/jbc.M109525200
Alam, A. (2014) Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets. Interdisciplinary Perspectives on Infectious Diseases, 2014, Article ID: 453186. http://dx.doi.org/10.1155/2014/453186
Zhao, Y., Yang, L. and Zhou, Z. (2014) Dipeptidyl Peptidase-4 Inhibitors: Multitarget Drugs, Not Only Antidiabetes Drugs. Journal of Diabetes, 6, 21-29. http://dx.doi.org/10.1111/1753-0407.12063
Patel, B.D. and Ghate, M.D. (2014) Recent Approaches to Medicinal Chemistry and Therapeutic Potential of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors. European Journal of Medicinal Chemistry, 74, 574-605. http://dx.doi.org/10.1016/j.ejmech.2013.12.038
Costa, A.G., Cusano, N.E., Silva, B.C., Cremers, S. and Bilezikian, J.P. (2011) Cathepsin K: Its Skeletal Actions and Role as a Therapeutic Target in Osteoporosis. Nature Reviews Rheumatology, 7, 447-456. http://dx.doi.org/10.1038/nrrheum.2011.77
Bromme, D. and Lecaille, F. (2009) Cathepsin K Inhibitors for Osteoporosis and Potential Off-Target Effects. Expert Opinion on Investigational Drugs, 18, 585-600. http://dx.doi.org/10.1517/13543780902832661
Zaqueo, K.D., Kayano, A.M., Simoes-Silva, R., Moreira-Dill, L.S., Fernandes, C.F., et al. (2014) Isolation and Biochemical Characterization of a New Thrombin-Like Serine Protease from Bothrops pirajai Snake Venom. BioMed Research International, 2014, Article ID: 595186. http://dx.doi.org/10.1155/2014/595186
Mukherjee, A.K. and Mackessy, S.P. (2013) Biochemical and Pharmacological Properties of a New Thrombin-Like Serine Protease (Russelobin) from the Venom of Russell’s Viper (Daboia russelii russelii) and Assessment of Its Therapeutic Potential. Biochimica et Biophysica Acta, 1830, 3476-3488. http://dx.doi.org/10.1016/j.bbagen.2013.02.007
Bekes, M., Rut, W., Kasperkiewicz, P., Mulder, M.P., Ovaa, H., et al. (2015) SARS hCoV Papain-Like Protease Is a Unique Lys48 Linkage-Specific Di-Distributive Deubiquitinating Enzyme. Biochemical Journal, 468, 215-226. http://dx.doi.org/10.1042/BJ20141170
Ksiazek, M., Karim, A.Y., Bryzek, D., Enghild, J.J., Thogersen, I.B., et al. (2015) Mirolase, a Novel Subtilisin-Like Serine Protease from the Periodontopathogen Tannerella forsythia. Biological Chemistry, 396, 261-275. http://dx.doi.org/10.1515/hsz-2014-0256
Montaser, R. and Luesch, H. (2011) Marine Natural Products: A New Wave of Drugs? Future Medicinal Chemistry, 3, 1475-1489.
Leung, D., Abbenante, G. and Fairlie, D.P. (2000) Protease Inhibitors: Current Status and Future Prospects. Journal of Medicinal Chemistry, 43, 305-341. http://dx.doi.org/10.1021/jm990412m
Cragg, G.M. and Newman, D.J. (2013) Natural Products: A Continuing Source of Novel Drug Leads. Biochimica et Biophysica Acta, 1830, 3670-3695. http://dx.doi.org/10.1016/j.bbagen.2013.02.008
Xue, Q., Itoh, N., Schey, K.L., Cooper, R.K. and La Peyre, J.F. (2009) Evidence Indicating the Existence of a Novel Family of Serine Protease Inhibitors That May Be Involved in Marine Invertebrate Immunity. Fish and Shellfish Immunology, 27, 250-259. http://dx.doi.org/10.1016/j.fsi.2009.05.006
Molinski, T.F., Dalisay, D.S., Lievens, S.L. and Saludes, J.P. (2009) Drug Development from Marine Natural Products. Nature Reviews Drug Discovery, 8, 69-85. http://dx.doi.org/10.1038/nrd2487
Iwanaga, S. and Lee, B.L. (2005) Recent Advances in the Innate Immunity of Invertebrate Animals. BMB Reports, 38, 128-150. http://dx.doi.org/10.5483/BMBRep.2005.38.2.128
Pascual, I., Gil-Parrado, S., Cisneros, M., Joseph-Bravo, P., Diaz, J., et al. (2004) Purification of a Specific Inhibitor of Pyroglutamyl Aminopeptidase II from the Marine Annelide Hermodice carunculata: In Vivo Effects in Rodent Brain. The International Journal of Biochemistry & Cell Biology, 36, 138-152. http://dx.doi.org/10.1016/S1357-2725(03)00175-4
Lopez-Abarrategui, C., Alba, A., Silva, O.N., Reyes-Acosta, O., Vasconcelos, I.M., et al. (2012) Functional Characterization of a Synthetic Hydrophilic Antifungal Peptide Derived from the Marine Snail Cenchritis muricatus. Biochimie, 94, 968-974. http://dx.doi.org/10.1016/j.biochi.2011.12.016
Gonzalez, Y., Tanaka, A.S., Hirata, I.Y., del Rivero, M.A., Oliva, M.L., et al. (2007) Purification and Partial Characterization of Human Neutrophil Elastase Inhibitors from the Marine Snail Cenchritis muricatus (Mollusca). Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 146, 506-513. http://dx.doi.org/10.1016/j.cbpa.2006.01.022
Delfin, J., Martinez, I., Antuch, W., Morera, V., Gonzalez, Y., et al. (1996) Purification, Characterization and Immobilization of Proteinase Inhibitors from Stichodactyla helianthus. Toxicon, 34, 1367-1376. http://dx.doi.org/10.1016/S0041-0101(96)00114-6
Alvarez, C., Mancheno, J.M., Martinez, D., Tejuca, M., Pazos, F., et al. (2009) Sticholysins, Two Pore-Forming Toxins Produced by the Caribbean Sea Anemone Stichodactyla helianthus: Their Interaction with Membranes. Toxicon, 54, 1135-1147. http://dx.doi.org/10.1016/j.toxicon.2009.02.022
Alonsodel-Rivero, M., Trejo, S.A., Reytor, M.L., Rodriguez-de-la-Vega, M., Delfin, J., et al. (2012) Tri-Domain Bifunctional Inhibitor of Metallocarboxypeptidases A and Serine Proteases Isolated from Marine Annelid Sabellastarte magnifica. Journal of Biological Chemistry, 287, 15427-15438. http://dx.doi.org/10.1074/jbc.M111.337261
Pascual, I., Gomez, H., Pons, T., Chappe, M., Vargas, M.A., et al. (2011) Effect of Divalent Cations on the Porcine Kidney Cortex Membrane-Bound form of Dipeptidyl Peptidase IV. The International Journal of Biochemistry & Cell Biology, 43, 363-371. http://dx.doi.org/10.1016/j.biocel.2010.11.006
Scopes, R.K. (1987) Protein Purification: Principles and Practice. 2nd Edition, Springer-Verlag, New York.
Sober, H.A., Harte, R.A. and Sober, E.K. (1968) Handbook of Biochemistry: Selected Data for Molecular Biology. Chemical Rubber Company CRC, Cleveland.
Nakajima, K., Powers, J.C., Ashe, B.M. and Zimmerman, M. (1979) Mapping the Extended Substrate Binding Site of Cathepsin G and Human Leukocyte Elastase. Studies with Peptide Substrates Related to the Alpha 1-Protease Inhibitor Reactive Site. The Journal of Biological Chemistry, 254, 4027-4032.
DelMar, E.G., Largman, C., Brodrick, J.W. and Geokas, M.C. (1979) A Sensitive New Substrate for Chymotrypsin. Analytical Biochemistry, 99, 316-320. http://dx.doi.org/10.1016/S0003-2697(79)80013-5
Nagatsu, T., Hino, M., Fuyamada, H., Hayakawa, T. and Sakakibara, S. (1976) New Chromogenic Substrates for X-Prolyl Dipeptidyl-Aminopeptidase. Analytical Biochemistry, 74, 466-476. http://dx.doi.org/10.1016/0003-2697(76)90227-X
Tchoupe, J.R., Moreau, T., Gauthier, F. and Bieth, J.G. (1991) Photometric or Fluorometric Assay of Cathepsin B, L and H and Papain Using Substrates with an Aminotrifluoromethylcoumarin Leaving Group. Biochimica et Biophysica Acta, 1076, 149-151. http://dx.doi.org/10.1016/0167-4838(91)90232-O
Falgueyret, J.P., Oballa, R.M., Okamoto, O., Wesolowski, G., Aubin, Y., et al. (2001) Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L. Journal of Medicinal Chemistry, 44, 94-104. http://dx.doi.org/10.1021/jm0003440
Copeland, R.A., Lombardo, D., Giannaras, J. and Decicco, C.P. (1995) Estimating KI Values for Tight Binding Inhibitors from Dose-Response Plots. Bioorganic & Medicinal Chemistry Letters, 5, 1947-1952. http://dx.doi.org/10.1016/0960-894X(95)00330-V
Motulsky, H. (2007) Prism 5 Statistics Guide. GraphPad Software, San Diego.
Bieth, J.G. (1995) Theoretical and Practical Aspects of Proteinase Inhibition Kinetics. Methods in Enzymology, 248, 59-84. http://dx.doi.org/10.1016/0076-6879(95)48007-2
Tagami, T., Tosa, R., Omura, M., Fukushima, H., Kaneko, T., et al. (2014) Effect of a Selective Neutrophil Elastase Inhibitor on Mortality and Ventilator-Free Days in Patients with Increased Extravascular Lung Water: A Post Hoc Analysis of the PiCCO Pulmonary Edema Study. Journal of Intensive Care, 2, 67. http://dx.doi.org/10.1186/s40560-014-0067-y
Yamazaki, S., Takayama, T., Moriguchi, M., Hayashi, Y., Mitsuka, Y., et al. (2015) Neutrophil Elastase Inhibitor Following Liver Resection: A Matched Cohort Study. Hepatitis Monthly, 15, e31235. http://dx.doi.org/10.5812/hepatmon.31235
Stoch, S.A., Zajic, S., Stone, J.A., Miller, D.L., van Bortel, L., et al. (2013) Odanacatib, a Selective Cathepsin K Inhibitor to Treat Osteoporosis: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics—Results from Single Oral Dose Studies in Healthy Volunteers. British Journal of Clinical Pharmacology, 75, 1240-1254. http://dx.doi.org/10.1111/j.1365-2125.2012.04471.x
Stoop, A.A. and Craik, C.S. (2003) Engineering of a Macromolecular Scaffold to Develop Specific Protease Inhibitors. Nature Biotechnology, 21, 1063-1068. http://dx.doi.org/10.1038/nbt860
Levy, J.H. and O’Donnell, P.S. (2006) The Therapeutic Potential of a Kallikrein Inhibitor for Treating Hereditary Angioedema. Expert Opinion on Investigational Drugs, 15, 1077-1090. http://dx.doi.org/10.1517/13543784.15.9.1077
Reytor, M.L., González, Y., Pascual, I., Hernández, A., Chávez, M.A., et al. (2011) Screening of Protease Inhibitory Activity in Extracts of Five Ascidian Species from Cuban Coasts. Biotecnología Aplicada, 28, 77-82.
Pascual, I., Lopéz, A., Gómez, H., Chappé, M., Saroyán, A., et al. (2007) Screening of Inhibitors of Porcine Dipeptidyl Peptidase IV Activity in Aqueous Extracts from Marine Organisms. Enzyme and Microbial Technology, 40, 414-419. http://dx.doi.org/10.1016/j.enzmictec.2006.07.012
Minagawa, S., Ishida, M., Shimakura, K., Nagashima, Y. and Shiomi, K. (1997) Isolation and Amino Acid Sequences of Two Kunitz-Type Protease Inhibitors from the Sea Anemone Anthopleura aff. xanthogrammica. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 118, 381-386. http://dx.doi.org/10.1016/S0305-0491(97)00174-0
Tschesche, H., Kolkenbrock, H. and Bode, W. (1987) The Covalent Structure of the Elastase Inhibitor from Anemonia sulcata—A “Non-Classical” Kazal-Type Protein. Biological Chemistry, 368, 1297-1304. http://dx.doi.org/10.1515/bchm3.1987.368.2.1297
Hemmi, H., Kumazaki, T., Yoshizawa-Kumagaye, K., Nishiuchi, Y., Yoshida, T., et al. (2005) Structural and Functional Study of an Anemonia Elastase Inhibitor, a “Nonclassical” Kazal-Type Inhibitor from Anemonia sulcata. Biochemistry, 44, 9626-9636. http://dx.doi.org/10.1021/bi0472806
La Barre, S., Longeon, A., Barthelemy, M., Guyot, M., Le Caer, J.P., et al. (1996) Characterization of a Novel Elastase Inhibitor from a Fan Coral. Comptes Rendus de l’Académie des Sciences-Series III, 319, 365-370.
Rimphanitchayakit, V. and Tassanakajon, A. (2010) Structure and Function of Invertebrate Kazal-Type Serine Proteinase Inhibitors. Developmental & Comparative Immunology, 34, 377-386. http://dx.doi.org/10.1016/j.dci.2009.12.004
Vicik, R., Busemann, M., Baumann, K. and Schirmeister, T. (2006) Inhibitors of Cysteine Proteases. Current Topics in Medicinal Chemistry, 6, 331-353. http://dx.doi.org/10.2174/156802606776287081
Nakao, Y., Fujita, M., Warabi, K., Matsunaga, S. and Fusetani, N. (2000) Miraziridine A, a Novel Cysteine Protease Inhibitor from the Marine Sponge Theonella aff. mirabilis. Journal of the American Chemical Society, 122, 10462-10463. http://dx.doi.org/10.1021/ja001859j
Fusetani, N., Fujita, M., Nakao, Y., Matsunaga, S. and Van Soest, R.W. (1999) Tokaramide A, a New Cathepsin B Inhibitor from the Marine Sponge Theonella aff. mirabilis. Bioorganic & Medicinal Chemistry Letters, 9, 3397-3402. http://dx.doi.org/10.1016/S0960-894X(99)00618-6
Salas-Sarduy, E., Cabrera-Munoz, A., Cauerhff, A., Gonzalez-Gonzalez, Y., Trejo, S.A., et al. (2013) Antiparasitic Effect of a Fraction Enriched in Tight-Binding Protease Inhibitors Isolated from the Caribbean Coral Plexaura homomalla. Experimental Parasitology, 135, 611-622. http://dx.doi.org/10.1016/j.exppara.2013.09.013